Skip to main content
. Author manuscript; available in PMC: 2022 May 12.
Published in final edited form as: N Engl J Med. 2021 Dec 1;385(25):2336–2347. doi: 10.1056/NEJMoa2108873

Figure 1. Screening, Randomization, and Treatment.

Figure 1.

The recurrence score based on the 21-gene breast-cancer assay ranges from 0 to 100, with higher scores indicating a worse prognosis.